Clear Labs Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
82
- Latest Deal Type
-
2ndary - Private
- Investors
-
25
Clear Labs General Information
Description
Operator of a comprehensive whole-genome sequencing platform intended to enhance pathogen surveillance and infectious disease outbreak management. The company's platform integrates automated sequencing with advanced bioinformatics, facilitating rapid detection and analysis of pathogens, enabling public health agencies and food safety organizations to improve response times and ensure consumer safety through precise genomic insights.
Contact Information
Website
www.clearlabs.comCorporate Office
- 1559 Industrial Road
- San Carlos, CA 94070
- United States
Corporate Office
- 1559 Industrial Road
- San Carlos, CA 94070
- United States
Clear Labs Timeline
Clear Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | 01-May-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series D) | 16-Jun-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C) | 26-May-2021 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 28-Aug-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B1) | 30-Oct-2018 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 30-Aug-2017 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Mar-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A2) | 05-Oct-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Feb-2014 | $1.05M | $1.05M | Completed | Generating Revenue | |
| 1. Angel (individual) | Completed | Startup |
Clear Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B1 | ||||||||
| Series B | ||||||||
| Series A2 | 6,333,936 | $0.000100 | $1.09 | $1.09 | 1x | $1.09 | 4.78% | |
| Series A | 4,928,517 | $0.000100 | $0.35 | $0.35 | 1x | $0.35 | 3.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Clear Labs Comparisons
Industry
Financing
Details
Clear Labs Competitors (12)
One of Clear Labs’s 12 competitors is Autogenomics, a Formerly VC-backed company based in Carlsbad, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Autogenomics | Formerly VC-backed | Carlsbad, CA | ||||
| LetsGetChecked | Venture Capital-Backed | Dublin, Ireland | ||||
| Flagship Biosciences | Formerly VC-backed | Broomfield, CO | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| Illumina | Formerly VC-backed | San Diego, CA |
Clear Labs Patents
Clear Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230417786-A1 | Fully automated sample processing platform from extraction to sequencing | Pending | 24-Jun-2022 | ||
| US-20230417787-A1 | Fully automated sample processing platform from extraction to sequencing | Pending | 24-Jun-2022 | ||
| US-11248265-B1 | Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens | Active | 19-Nov-2020 | ||
| US-12305231-B2 | Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens | Active | 19-Nov-2020 | ||
| US-20220154270-A1 | Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens | Active | 19-Nov-2020 | C12Q1/689 |
Clear Labs Signals
Clear Labs Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Athena Capital (New York) | Other Private Equity | Minority | ||
| Angel (individual) | Minority | |||
| Morgan Stanley | Investment Bank | Minority | ||
| Counterpoint Global | Asset Manager | Minority | ||
| Dafgårds | Corporation | Minority |
Clear Labs FAQs
-
When was Clear Labs founded?
Clear Labs was founded in 2014.
-
Where is Clear Labs headquartered?
Clear Labs is headquartered in San Carlos, CA.
-
What is the size of Clear Labs?
Clear Labs has 82 total employees.
-
What industry is Clear Labs in?
Clear Labs’s primary industry is Other Healthcare Technology Systems.
-
Is Clear Labs a private or public company?
Clear Labs is a Private company.
-
What is Clear Labs’s current revenue?
The current revenue for Clear Labs is .
-
How much funding has Clear Labs raised over time?
Clear Labs has raised $173M.
-
Who are Clear Labs’s investors?
Athena Capital (New York), , Morgan Stanley, Counterpoint Global, and Dafgårds are 5 of 25 investors who have invested in Clear Labs.
-
Who are Clear Labs’s competitors?
Autogenomics, LetsGetChecked, Flagship Biosciences, Oxford Nanopore Technologies, and Illumina are some of the 12 competitors of Clear Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process